| # | Drug | Count |
|---|---|---|
| 0 | BLEOMYCIN SULFATE | 9 |
| 1 | HYDROXYUREA | 7 |
| 2 | VENLAFAXINE HYDROCHLORIDE | 7 |
| 3 | FINASTERIDE | 6 |
| 4 | IPILIMUMAB | 6 |
| 5 | MIRTAZAPINE | 6 |
| 6 | DACARBAZINE | 5 |
| 7 | VINBLASTINE SULFATE | 5 |
| 8 | CISPLATIN | 4 |
| 9 | ETOPOSIDE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VINBLASTINE SULFATE | 5 | 0.0025 |
| 1 | AMOXAPINE | 1 | 0.0021 |
| 2 | BLEOMYCIN SULFATE | 9 | 0.0009 |
| 3 | DACARBAZINE | 5 | 0.0007 |
| 4 | HYDROXYUREA | 7 | 0.0003 |
| 5 | FLUVASTATIN SODIUM | 1 | 0.0002 |
| 6 | ZONISAMIDE | 2 | 0.0002 |
| 7 | AMISULPRIDE | 1 | 0.0002 |
| 8 | IPILIMUMAB | 6 | 0.0001 |
| 9 | PAROXETINE HYDROCHLORIDE HEMIHYDRATE | 4 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 1 | Recombinant Human Growth Hormone [EPC] | 3 | 0.0001 |
| 2 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 6 | 0.0001 |
| 4 | 5-alpha Reductase Inhibitor [EPC] | 6 | 0.0001 |
| 5 | Topoisomerase Inhibitor [EPC] | 4 | 0.0001 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 4 | 0.0000 |
| 7 | Macrolide Antimicrobial [EPC] | 2 | 0.0000 |
| 8 | Aminosalicylate [EPC] | 3 | 0.0000 |
| 9 | Alkylating Drug [EPC] | 5 | 0.0000 |